Literature DB >> 25837266

COUNTERPOINT: Does the Risk of Electronic Cigarettes Exceed Potential Benefits? No.

Holly R Middlekauff1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25837266     DOI： 10.1378/chest.15-0540

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  11 in total

1.  Society of Behavioral Medicine's (SBM) position on emerging policy issues regarding electronic nicotine delivery systems (ENDS): A need for regulation.

Authors:  Alana M Rojewski; Nortorious Coleman; Benjamin A Toll
Journal:  Transl Behav Med       Date:  2016-09       Impact factor: 3.046

Review 2.  Profiling the Acute Effects of Modified Risk Products: Evidence from the SUR-VAPES (Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking) Cluster Study.

Authors:  Giacomo Frati; Roberto Carnevale; Cristina Nocella; Mariangela Peruzzi; Antonino G M Marullo; Elena De Falco; Isotta Chimenti; Vittoria Cammisotto; Valentina Valenti; Elena Cavarretta; Albino Carrizzo; Francesco Versaci; Matteo Vitali; Carmela Protano; Leonardo Roever; Arturo Giordano; Sebastiano Sciarretta; Giuseppe Biondi-Zoccai
Journal:  Curr Atheroscler Rep       Date:  2020-02-07       Impact factor: 5.113

3.  Tobacco and electronic cigarettes adversely impact ECG indexes of ventricular repolarization: implication for sudden death risk.

Authors:  Michelle Ip; Evangelos Diamantakos; Kacey Haptonstall; Yasmine Choroomi; Roya S Moheimani; Kevin Huan Nguyen; Elizabeth Tran; Jeffrey Gornbein; Holly R Middlekauff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-20       Impact factor: 4.733

4.  Practice Patterns and Perceptions of Chest Health Care Providers on Electronic Cigarette Use: An In-Depth Discussion and Report of Survey Results.

Authors:  Stephen R Baldassarri; Geoffrey L Chupp; Frank T Leone; Graham W Warren; Benjamin A Toll
Journal:  J Smok Cessat       Date:  2017-04-09

5.  Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk.

Authors:  Roya S Moheimani; May Bhetraratana; Fen Yin; Kacey M Peters; Jeffrey Gornbein; Jesus A Araujo; Holly R Middlekauff
Journal:  JAMA Cardiol       Date:  2017-03-01       Impact factor: 30.154

6.  Sympathomimetic Effects of Acute E-Cigarette Use: Role of Nicotine and Non-Nicotine Constituents.

Authors:  Roya S Moheimani; May Bhetraratana; Kacey M Peters; Benjamin K Yang; Fen Yin; Jeffrey Gornbein; Jesus A Araujo; Holly R Middlekauff
Journal:  J Am Heart Assoc       Date:  2017-09-20       Impact factor: 5.501

Review 7.  Smoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal?

Authors:  Michelle L Giles; Coral Gartner; Mark A Boyd
Journal:  AIDS Res Ther       Date:  2018-12-12       Impact factor: 2.250

8.  Acute Effects of Heat-Not-Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking ( SUR - VAPES ) 2 Randomized Trial.

Authors:  Giuseppe Biondi-Zoccai; Sebastiano Sciarretta; Christopher Bullen; Cristina Nocella; Francesco Violi; Lorenzo Loffredo; Pasquale Pignatelli; Ludovica Perri; Mariangela Peruzzi; Antonino G M Marullo; Elena De Falco; Isotta Chimenti; Vittoria Cammisotto; Valentina Valenti; Flaminia Coluzzi; Elena Cavarretta; Albino Carrizzo; Francesco Prati; Roberto Carnevale; Giacomo Frati
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

9.  Worldviews and trust of sources for health information on electronic nicotine delivery systems: Effects on risk perceptions and use.

Authors:  Scott R Weaver; Amelia Jazwa; Lucy Popova; Paul Slovic; Richard B Rothenberg; Michael P Eriksen
Journal:  SSM Popul Health       Date:  2017-09-29

Review 10.  Electronic cigarettes: an aid in smoking cessation, or a new health hazard?

Authors:  Konstantinos Farsalinos
Journal:  Ther Adv Respir Dis       Date:  2017-12-07       Impact factor: 4.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.